PMID- 22025997
OWN - NLM
STAT- MEDLINE
DCOM- 20120301
LR  - 20210227
IS  - 1936-7163 (Electronic)
IS  - 0033-6572 (Linking)
VI  - 42
IP  - 10
DP  - 2011 Nov-Dec
TI  - Oily calcium hydroxide suspension in the treatment of infrabony periodontal 
      defects: a randomized controlled clinical trial.
PG  - 835-42
AB  - OBJECTIVE: To evaluate the efficacy of oily calcium hydroxide suspension (OCHS) 
      in the of treatment of infrabony defects. METHOD AND MATERIALS: Thirty patients 
      with advanced chronic periodontitis, with one deep infrabony defect, were 
      randomly treated with open flap debridement (OFD) (control) or OFD + OCHS (test). 
      Clinical measurements were performed at baseline and 9 months after treatment. 
      Surgical reentry was performed after 9 months. The primary outcome variables were 
      reduction in probing pocket depth (PPD) and gain in relative attachment level 
      (RAL). The secondary outcome was the reduction in depth of defect (DOD) measured 
      intrasurgically. RESULTS: A statistically significant reduction in PPD was 
      observed at the end of 9 months, with the control group showing a mean reduction 
      of 2.06 +/- 0.59 mm from baseline to 9 months and the test 1.06 +/- 1.22 mm (P >/= 
      .05). There was no statistically significant gain in RAL at the end of 9 months, 
      with a mean of 0.60 +/- 0.50 mm in the control group and 0.60 +/- 0.91 mm in the test 
      (P >/= .05). No statistically significant difference was observed in DOD at 9 
      months, with a mean difference of 0.80 +/- 0.77 mm in the control group and 0.66 +/- 
      0.97 mm in the test (P >/= .05). CONCLUSION: Within the limitations of the study, 
      OCHS failed to demonstrate any superior clinical outcomes in comparison with OFD.
FAU - Aparna, S
AU  - Aparna S
AD  - Department of Periodontics, Bangalore Institute of Dental Sciences and 
      Postgraduate Research Center, Bangalore, India. aparna_bds@yahoo.co.in
FAU - Setty, Swati
AU  - Setty S
FAU - Thakur, Srinath
AU  - Thakur S
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - Germany
TA  - Quintessence Int
JT  - Quintessence international (Berlin, Germany : 1985)
JID - 0342677
RN  - 0 (Bone Substitutes)
RN  - 0 (Fatty Acids)
RN  - 0 (Suspensions)
RN  - PF5DZW74VN (Calcium Hydroxide)
MH  - Adult
MH  - Alveolar Bone Loss/classification/*surgery
MH  - Bone Substitutes/*therapeutic use
MH  - Calcium Hydroxide/*therapeutic use
MH  - Chronic Periodontitis/surgery
MH  - Debridement
MH  - Fatty Acids/*therapeutic use
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Periodontal Attachment Loss/classification/surgery
MH  - Periodontal Pocket/classification/surgery
MH  - Radiography, Bitewing
MH  - Surgical Flaps
MH  - Suspensions
MH  - Treatment Outcome
EDAT- 2011/10/26 06:00
MHDA- 2012/03/02 06:00
CRDT- 2011/10/26 06:00
PHST- 2011/10/26 06:00 [entrez]
PHST- 2011/10/26 06:00 [pubmed]
PHST- 2012/03/02 06:00 [medline]
AID - 840457 [pii]
PST - ppublish
SO  - Quintessence Int. 2011 Nov-Dec;42(10):835-42.